Jersey Shore NJ
Puma Biotechnology Licensing Partner Pint Pharma Receives Marketing Authorization for NERLYNX (neratinib) for Extended Adjuvant Treatment of Early Stage Hormone...
LOS ANGELES--(BUSINESS WIRE)--Sep 4, 2019-- |!| Atlantic City
